Literature DB >> 17154225

Fetal cardiomyopathy--in utero evaluation and clinical significance.

Yoav Yinon1, Simcha Yagel, Juluis Hegesh, Boaz Weisz, Shali Mazaki-Tovi, Shlomo Lipitz, Reuven Achiron.   

Abstract

OBJECTIVE: To describe the prenatal diagnosis and outcome of fetal cardiomyopathy (CM).
METHODS: The charts, photographs and videotapes of all fetuses with CM, who were assessed during pregnancy at two referral centers, were reviewed.
RESULTS: The diagnosis of CM was established in 12 fetuses. All had structurally normal hearts, and all cases were diagnosed after 23 weeks of gestation, following normal early fetal echocardiogram. Three clusters of fetal CM appeared: Familial--two sib fetuses of a mother, who is a second generation of CM. Both had dilated CM and pathological findings were consistent with the diagnosis of endocardial fibroelastosis. Secondary--CM that was induced by another factor. Idiopathic--six cases of CM without an underlying specific etiology. Three women elected to terminate their pregnancy. Among the nine who delivered, four had a favorable outcome with normal cardiac function at the age of 1 month, in which three belonged to the secondary category, and five cases were complicated by fetal/infant death.
CONCLUSIONS: CM may develop during fetal life and might be diagnosed by prenatal echocardiography. Normal cardiac findings in a midtrimester fetus do not exclude subsequent development of CM. Detailed prenatal sonographic examination may aid in determining the neonatal outcome. Copyright 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2007        PMID: 17154225     DOI: 10.1002/pd.1612

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  5 in total

1.  Comparison of Immune Profiles in Fetal Hearts with Idiopathic Dilated Cardiomyopathy, Maternal Autoimmune-Associated Dilated Cardiomyopathy and the Normal Fetus.

Authors:  Lynne E Nield; Ingo von Both; Najla Popel; Kate Strachan; Cedric Manlhiot; Patrick Shannon; Brian W McCrindle; Adelle Atkinson; Steven E S Miner; Edgar T Jaeggi; Glenn P Taylor
Journal:  Pediatr Cardiol       Date:  2015-10-20       Impact factor: 1.655

2.  Factors associated with in utero demise of fetuses that have underlying cardiac pathologies.

Authors:  Christine E MacColl; Cedric Manlhiot; Christiana Page; Brian W McCrindle; Steven E S Miner; Edgar T Jaeggi; Lynne E Nield
Journal:  Pediatr Cardiol       Date:  2014-06-14       Impact factor: 1.655

3.  Fetal Left Ventricular Apical Aneurysm Progressing to Dilated Cardiomyopathy Due to Glycogen Storage Disease.

Authors:  Geetha Challapudi; Gerard J Boyle; E Rene Rodriguez; Rukmini Komarlu
Journal:  Tex Heart Inst J       Date:  2022-07-01

4.  Features and outcomes in utero and after birth of fetuses with myocardial disease.

Authors:  Vlasta Fesslova; Maurizio Mongiovì; Salvatore Pipitone; Jelena Brankovic; Laura Villa
Journal:  Int J Pediatr       Date:  2010-10-03

5.  Fetal Echocardiography is Useful for Screening Fetuses with a Family History of Cardiomyopathy.

Authors:  Nicholas B Zaban; Robert K Darragh; John J Parent
Journal:  Pediatr Cardiol       Date:  2020-08-25       Impact factor: 1.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.